Oxymatrine inhibited cell proliferation by inducing apoptosis in human lung cancer A549 cells

Bio-Medical Materials and Engineering

Volumn 26, Issue , 2015, Pages S165-S172

  Wang, Baiyan ^a   Han, Qianqian ^a   Zhu, Yanqin ^a  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

A549 cells; apoptosis; Bax; Bcl 2; Oxymatrine; proliferation inhibition

Indexed keywords

BIOLOGICAL ORGANS; CELL DEATH; CELL PROLIFERATION; CELLS; CYTOLOGY; DISEASES; MORPHOLOGY; POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM;

A549 CELLS; BCL-2; EXPRESSION OF BCL-2 AND BAX; MORPHOLOGICAL CHANGES; OXYMATRINE; POSITIVE CONTROL GROUP; PROLIFERATION INHIBITION; REAL-TIME QUANTITATIVE PCR;

DRUG PRODUCTS;

FLUOROURACIL; MESSENGER RNA; OXYMATRINE; PROTEIN BAX; PROTEIN BCL 2; ALKALOID; ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; HERBACEOUS AGENT; QUINOLIZINE DERIVATIVE;

A-549 CELL LINE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; DRUG EFFECTS; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE;

ALKALOIDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINOLIZINES; TREATMENT OUTCOME;

EID: 84978878273     PISSN: 09592989     EISSN: 18783619     Source Type: Journal    
DOI: 10.3233/BME-151302     Document Type: Article

References (12)

1. Y. Zhang, H. Zhang, P.F. Yu, et al. Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology 59 (2009), 191-200.
2. J. Liu. Y.Z. Yao, H.F. Ding, and R.N. Chen, Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells, Tumor Biology 35 (2014), 5409-5415.
3. Y.P. Niu, L.D. Li, and L.M. Wu. Beta-Aescin: A potent natural inhibitor of proliferation and inducer of apoptosis in human chronic myeloid leukemia K562 cells in vitro. Leukemia & Lymphoma 49 (2008), 1384-1391.
4. Y. Liu, Y. Xu, and W.D. Ji et al. Anti-Tumor activities of matrine and oxymatrine: Literature review. Tumor Biology 35 (2014), 5111-5119.
5. F.H. Cao, W.Q. OuYang, Y.P. Wang, P.F. Yue, and S.P. Li. A Combination of a microemulsion and a phospholipid complex for topical delivery of oxymatrine. Archives of Pharmacal Research 34 (2011), 551-562.
6. Z.T. Yang, R.L. Yin, and Y.F. Cong et al. Oxymatrine lightened the inflammatory response of LPS-induced mastitis in mice through affecting NF-?B and MAPKs signaling pathways. Inflammation 37 (2014), 2047-2055.
7. B. Zhu, J.R. Yang, S.F. Chen, and Y.Q. Jiang. The attenuation of lung ischemia reperfusion injury by oxymatrine. Cell Biochemistry and Biophysics 70 (2014), 333-336.
8. X.P. Yuan, Y.Y. Wang, D.R. Du, Z. Hu, M.X. Xu, M.B. Xu, and Z.F. Liu. The effects of the combination of sodium ferulate and oxymatrine on lipopolysaccharide-induced acute lung injury in mice. Inflammation 35 (2012), 1161-1168.
9. Y.G. Cao et al. Antiarrhythmic effects and ionic mechanisms of oxymatrine from sophora flavescens. Phytotherapy Research 24 (2010), 1844-1849.
10. B.Y. Guo, T.T. Zhang, J.Y. Su et al. Oxymatrine targets EGFRp-Tyr845 and inhibits EGFR related signaling pathways to suppress the proliferation and invasion of gastric cancer cells. Cancer Chemotherapy and Pharmacology 75 (2015), 353-363.
11. Q. Ling, X. Xu, X.Y. Wei et al. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. Journal of Experimental & Clinical Cancer Research 30 (2011), 30-66.
12. J.H. Wei, Y. Zhu, G. Xu et al. Oxymatrine extracted from sophora flavescens inhibited cell growth and induced apoptosis in human osteosarcoma MG-63 cells in vitro. Cell Biochemistry and Biophysics 70 (2014), 1439-1444.